日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results

吉西他滨膀胱灌注系统联合西曲利单抗或单用西曲利单抗作为肌层浸润性膀胱癌新辅助治疗:SunRISe-4 主要分析和生物标志物结果

Necchi, Andrea; Guerrero-Ramos, Félix; Crispen, Paul L; Herrera-Imbroda, Bernardo; Garje, Rohan; Szabados, Bernadett; Peyton, Charles C; Pradere, Benjamin; Ku, Ja Hyeon; Shore, Neal; Bögemann, Martin; Preston, Mark A; Xylinas, Evanguelos; Sanchez de Llano, Cristina; Gong, Cinty; Hasan, Mohamad; Urtishak, Karen; Battaglia, Sebastiano; Stitou, Hind; Bhanvadia, Sumeet; Sweiti, Hussein; Psutka, Sarah P

Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial

古塞库单抗与戈利木单抗治疗活动性银屑病关节炎且对初始肿瘤坏死因子抑制剂反应不足的患者:EVOLUTION 研究方案,一项实用性、3b 期、开放标签、随机、对照有效性试验

Ogdie, Alexis; Reddy, Soumya M; Gillespie, Sarah H; Husni, M Elaine; Scher, Jose U; Salomon-Escoto, Karen; Kay, Jonathan; Luedders, Brent A; Curtis, Jeffrey R; Shields, Alisa J Stephens; Chakravarty, Soumya D; Gong, Cinty; Walsh, Jessica A

BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies

BASDAI 与 ASDAS 在评估银屑病关节炎患者轴向受累情况中的比较:两项 3 期研究的汇总分析

Baraliakos, Xenofon; Gladman, Dafna D; Chakravarty, Soumya D; Gong, Cinty; Shawi, May; Rampakakis, Emmanouil; Kishimoto, Mitsumasa; Soriano, Enrique R; Mease, Philip J

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study

在 GO-ALIVE 3 期研究中,静脉注射戈利木单抗对活动性强直性脊柱炎成人患者疲劳的影响及其与临床反应的关系

Deodhar, Atul; Shiff, Natalie J; Gong, Cinty; Chan, Eric K H; Hsia, Elizabeth C; Lo, Kim Hung; Akawung, Alianu; Kim, Lilianne; Xu, Stephen; Reveille, John D

Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial

古塞库单抗治疗既往未接受过生物制剂治疗的活动性中轴型银屑病关节炎患者的疗效和安全性:STAR 研究方案,一项 4 期随机、双盲、安慰剂对照试验

Gladman, Dafna D; Mease, Philip J; Bird, Paul; Soriano, Enrique R; Chakravarty, Soumya D; Shawi, May; Xu, Stephen; Quinn, Sean T; Gong, Cinty; Leibowitz, Evan; Poddubnyy, Denis; Tam, Lai-Shan; Helliwell, Philip S; Kavanaugh, Arthur; Deodhar, Atul; Østergaard, Mikkel; Baraliakos, Xenofon

Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study

GO-ALIVE 研究一年内静脉注射戈利木单抗治疗早期和晚期强直性脊柱炎患者的疗效和安全性

Deodhar, Atul A; Shiff, Natalie J; Gong, Cinty; Hsia, Elizabeth C; Lo, Kim Hung; Kim, Lilliane; Xu, Stephen; Reveille, John D